Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...
The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...
The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback